The FDA has accepted two artificial formulations of THC for managing unique problems: nabilone and dronabinol.THC targets receptors within a manner less selective than endocannabinoid molecules, and its pharmacodynamic tolerance may well Restrict maximal consequences of specified medicine though enhancing the drug's therapeutic window.One of the mo